These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12189926)

  • 1. [Contemporary diagnosis of increased sympathetic activity: the ups and downs].
    Luciak M
    Pol Arch Med Wewn; 2002 Apr; 107(4):345-7. PubMed ID: 12189926
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?
    Hausberg M; Grassi G
    J Hypertens; 2007 Jan; 25(1):47-9. PubMed ID: 17143171
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Silent" myocardial ischemia and the activity of the sympathetic-adrenal system in hypertension patients].
    Iurenev AP; De Quattro V; Titov VN; Guliaev VP; Kuz'min AI; Koniaeva EB
    Ter Arkh; 1991; 63(9):83-7. PubMed ID: 1836901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system and hypertension: recent developments.
    DiBona GF
    Hypertension; 2004 Feb; 43(2):147-50. PubMed ID: 14707153
    [No Abstract]   [Full Text] [Related]  

  • 6. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?
    Rump LC; Amann K; Orth S; Ritz E
    Nephrol Dial Transplant; 2000 Nov; 15(11):1735-8. PubMed ID: 11071955
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic activation in chronic renal failure.
    Schlaich MP; Socratous F; Hennebry S; Eikelis N; Lambert EA; Straznicky N; Esler MD; Lambert GW
    J Am Soc Nephrol; 2009 May; 20(5):933-9. PubMed ID: 18799718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activation in chronic kidney disease: out of the shadow.
    Schlaich MP
    Hypertension; 2011 Apr; 57(4):683-5. PubMed ID: 21300664
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathetic nervous system as a coronary risk factor in hypertension.
    Julius S; Nesbitt SD
    Cardiologia; 1996 Apr; 41(4):309-17. PubMed ID: 8674099
    [No Abstract]   [Full Text] [Related]  

  • 11. Sympathetic nervous system: role in hypertension and in chronic kidney disease.
    Grassi G; Bertoli S; Seravalle G
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):46-51. PubMed ID: 22080859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology I: the kidney and the sympathetic nervous system.
    de Jager RL; Blankestijn PJ
    EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early sympathetic activation in the initial clinical stages of chronic renal failure.
    Grassi G; Quarti-Trevano F; Seravalle G; Arenare F; Volpe M; Furiani S; Dell'Oro R; Mancia G
    Hypertension; 2011 Apr; 57(4):846-51. PubMed ID: 21300663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and coronary heart disease.
    Baguet JP; Mallion JM
    Blood Press; 2003; 12(4):255-6. PubMed ID: 14596363
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM
    Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal neural activity in hepatorenal syndrome.
    DiBona GF
    Kidney Int; 1984 May; 25(5):841-53. PubMed ID: 6471670
    [No Abstract]   [Full Text] [Related]  

  • 17. An appropriate SCORE to assess cardiovascular risk in hypertension?
    Hedner T; Narkiewicz K; Oparil S; Kjeldsen S
    Blood Press; 2011 Dec; 20(6):320-1. PubMed ID: 22077635
    [No Abstract]   [Full Text] [Related]  

  • 18. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question.
    Julius S; Jamerson K
    J Hypertens; 1994 May; 12(5):495-502. PubMed ID: 7930548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pressor and depressor factors in the pathogenesis of stenocardia in hypertension].
    Grigor'eva ZE
    Vrach Delo; 1978 Aug; (8):53-7. PubMed ID: 695507
    [No Abstract]   [Full Text] [Related]  

  • 20. Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.
    Julius S
    Hypertension; 1993 Jun; 21(6 Pt 2):886-93. PubMed ID: 8505097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.